FA
GILD icon

Faithward Advisors’s Gilead Sciences GILD Stock Holding History

Faithward Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Buy
+3,229
New +$425K 0.05% 231
2026
Q1 		– Sell
-2,783
Closed -$342K – 287
2025
Q4 		$342K Buy
2,783
+528
+23% +$64.2K 0.05% 243
2025
Q3 		$250K Buy
2,255
+396
+21% +$45K 0.04% 270
2025
Q2 		$206K Hold
1,859
– – 0.03% 258
2025
Q1 		$208K Buy
+1,859
New +$192K 0.04% 249

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Faithward Advisors's GILD Position: Q2 2026 in Review

Faithward Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,229 shares worth $408K. The stake represents 0.05% of the portfolio and ranks #231 among its holdings. This is a return to the name: Faithward Advisors previously reported a position in GILD as recently as Q4 2025.

Faithward Advisors first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Faithward Advisors held 3,229 shares of Gilead Sciences worth $408K as of Q2 2026.
  • Gilead Sciences was a new Faithward Advisors position in Q2 2026.
  • Gilead Sciences made up 0.05% of Faithward Advisors's portfolio in Q2 2026, its #231 holding.
  • Faithward Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.